

Although the company achieved a revenue increase, primarily from its international activities, its share price fell slightly amid fears that inventory levels and margin pressure could restrict future growth. Meanwhile, Under Armour is another firm causing concern among analysts due to inventory problems. Posted: Full-Time What Inventory Management contributes to Cardinal Health. According to a statement, Cardinal Health expects Cordis to be on “a path to profitable growth” by the end of 2019. The company has struggled to sell its medical devices before their expiry dates, resulting in a large inventory write-off in the third quarter. With 376 billion of assets under management, Carlyles purpose is to invest wisely and create value on behalf of our investors, portfolio companies. CEO Michael Kaufmann is quoted as saying that building an infrastructure outside of the US has been “more expensive than we thought, it hasn’t gone as well as we thought”.

Since purchasing the Cordis business from Johnson & Johnson in 2015, Cardinal Health has faced ongoing operational difficulties regarding inventory. As a result, the share price dropped by more than 18%, bringing it close to its four-and-a-half-year low. This followed inventory write-downs in its Cordis business – the medical device unit which includes equipment such as catheters and stents – combined with a bigger than expected drop in generic drug prices. announced disappointing results for its last quarter and reduced its full-year outlook. You can read more about our approach to ESG data here.Earlier this month, two publicly listed companies saw the price of their shares fall sharply following reports of inventory issues: Cardinal Health Inc., a US-based wholesaler of drugs and medical supplies, and Under Armour, an American sportswear manufacturer.Ĭardinal Health Inc. ESG data is a core tool we use during the investment period to drive value – we track ESG key performance indicators (KPIs) across our investments for issues which are systemically important (such as diversity of boards and management teams), and several of our larger funds also track bespoke, material ESG KPIs for each controlled portfolio company.
#Cardinal inventory manager upgrade
Our goal is to provide distinct resources that allow portfolio companies to develop ESG and impact approaches beyond what they may have otherwise: capital injections to upgrade equipment and advance R&D, support from our dedicated internal ESG professionals, connections to leading experts in ESG issues in their sector, institutional knowledge of best practices and reporting, and the leverage of other firm resources including cross-portfolio collaboration between our companies. We support portfolio companies to both evaluate ESG issues related to their businesses and develop their own internal capacity to manage these issues and opportunities, if not already in place. Once we own a particular portfolio company or asset, we monitor material ESG issues and assess opportunities to generate value from ESG initiatives and growth markets.
